The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2015

Filed:

Aug. 18, 2009
Applicants:

Arvydas Usas, Pittsburgh, PA (US);

Karin Payne, Pittsburgh, PA (US);

Thomas Payne, Pittsburgh, PA (US);

Ronald Jankowski, Pittsburgh, PA (US);

Johnny Huard, Waxford, PA (US);

Inventors:

Arvydas Usas, Pittsburgh, PA (US);

Karin Payne, Pittsburgh, PA (US);

Thomas Payne, Pittsburgh, PA (US);

Ronald Jankowski, Pittsburgh, PA (US);

Johnny Huard, Waxford, PA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/38 (2006.01); A61K 35/38 (2015.01); C12N 5/077 (2010.01); A61L 27/36 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01); C12N 11/02 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61L 27/3895 (2013.01); A61K 35/38 (2013.01); A61L 27/365 (2013.01); A61L 27/3629 (2013.01); A61L 27/3847 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); C12N 5/0659 (2013.01); C12N 11/02 (2013.01); A61K 35/12 (2013.01); A61L 2300/64 (2013.01); A61L 2430/02 (2013.01); A61L 2430/40 (2013.01); C12N 2533/92 (2013.01);
Abstract

The present invention provides muscle-derived progenitor cells that show long-term survival following transplantation into body tissues and which can augment non-soft tissue following introduction (e.g. via injection, transplantation, or implantation) into a site of non-soft tissue (e.g. bone) when combined with a biocompatible matrix, preferably SIS. The invention further provides methods of using compositions comprising muscle-derived progenitor cells with a biocompatible matrix for the augmentation and bulking of mammalian, including human, bone tissues in the treatment of various functional conditions, including osteoporosis, Paget's Disease, osteogenesis imperfecta, bone fracture, osteomalacia, decrease in bone trabecular strength, decrease in bone cortical strength and decrease in bone density with old age.


Find Patent Forward Citations

Loading…